Humanigen Inc (fka HGENQ)

[cowtown jay]

We're tracking Novovax, the company I have long considered a model. Lots of similarities, but important distinctions, as well.

In the early winter of 21, NVAX was trading in the $3 range, as we are. They have an enviable share structure, but our OS is even lower. They were the front-runner vaccine, as we are the front-runner therapeutic.

By May of 21, NVAX was trading at $46. Just over a year from when they were trading in the $3 range, they reached what remains their all-time high of over $300.

As dangerous as Covid was to the world last year, without vaccines, I think it is even more dangerous now, with ineffective vaccines. And only our patent-protected lenz will prevent disease progression of hospitalized and hypoxic patients.

I was hoping for some news this morning from Durrant regarding Kessler procuring all the lenz we could supply to the White House Covid task force.

I remain optimistic...but extremely anxious, as well. Come on, Cameron, stick the landing. And if they don't want to pay what we will be getting from Europe, I don't think they should, anyway. They need to pay more for causing the dilution of our share value.